CN111973471A - Cosmetic composition - Google Patents
Cosmetic composition Download PDFInfo
- Publication number
- CN111973471A CN111973471A CN201910440904.9A CN201910440904A CN111973471A CN 111973471 A CN111973471 A CN 111973471A CN 201910440904 A CN201910440904 A CN 201910440904A CN 111973471 A CN111973471 A CN 111973471A
- Authority
- CN
- China
- Prior art keywords
- parts
- peg
- cosmetic composition
- composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 71
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 52
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 27
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 27
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 26
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 26
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 26
- 239000004475 Arginine Substances 0.000 claims abstract description 26
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 26
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 26
- 229960000458 allantoin Drugs 0.000 claims abstract description 26
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 26
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 26
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000009697 arginine Nutrition 0.000 claims abstract description 26
- 229940036350 bisabolol Drugs 0.000 claims abstract description 26
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 26
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 26
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 25
- 235000011187 glycerol Nutrition 0.000 claims abstract description 25
- 229940101267 panthenol Drugs 0.000 claims abstract description 25
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 25
- 239000011619 pantothenol Substances 0.000 claims abstract description 25
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 24
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 18
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 18
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 3
- 229960003121 arginine Drugs 0.000 claims abstract description 3
- 229960005150 glycerol Drugs 0.000 claims abstract description 3
- 229940074410 trehalose Drugs 0.000 claims abstract description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 52
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 31
- 238000002156 mixing Methods 0.000 claims description 30
- -1 polydimethylsiloxane Polymers 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 26
- 239000003995 emulsifying agent Substances 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 23
- 239000002562 thickening agent Substances 0.000 claims description 23
- 229930182478 glucoside Natural products 0.000 claims description 22
- 150000008131 glucosides Chemical class 0.000 claims description 22
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 22
- 229940032094 squalane Drugs 0.000 claims description 22
- 239000000230 xanthan gum Substances 0.000 claims description 22
- 229920001285 xanthan gum Polymers 0.000 claims description 22
- 235000010493 xanthan gum Nutrition 0.000 claims description 22
- 229940082509 xanthan gum Drugs 0.000 claims description 22
- 238000010438 heat treatment Methods 0.000 claims description 21
- 239000003755 preservative agent Substances 0.000 claims description 19
- 230000002335 preservative effect Effects 0.000 claims description 18
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 16
- 239000004698 Polyethylene Substances 0.000 claims description 16
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 16
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- 229920000573 polyethylene Polymers 0.000 claims description 16
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 16
- 150000005846 sugar alcohols Polymers 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 10
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 8
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims description 8
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 8
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 claims description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 8
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- 239000005711 Benzoic acid Substances 0.000 claims description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 8
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 8
- 235000010489 acacia gum Nutrition 0.000 claims description 8
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 235000010233 benzoic acid Nutrition 0.000 claims description 8
- 229960004365 benzoic acid Drugs 0.000 claims description 8
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 8
- 229960001631 carbomer Drugs 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 8
- 235000010418 carrageenan Nutrition 0.000 claims description 8
- 229920001525 carrageenan Polymers 0.000 claims description 8
- 229940113118 carrageenan Drugs 0.000 claims description 8
- 239000004359 castor oil Substances 0.000 claims description 8
- 235000019438 castor oil Nutrition 0.000 claims description 8
- 229940071160 cocoate Drugs 0.000 claims description 8
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 8
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 8
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 8
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 8
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 8
- 229940119170 jojoba wax Drugs 0.000 claims description 8
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 8
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 8
- 229960005323 phenoxyethanol Drugs 0.000 claims description 8
- 239000004302 potassium sorbate Substances 0.000 claims description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims description 8
- 229940069338 potassium sorbate Drugs 0.000 claims description 8
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 8
- 229960003415 propylparaben Drugs 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 229940083542 sodium Drugs 0.000 claims description 8
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- 229960003885 sodium benzoate Drugs 0.000 claims description 8
- 235000010199 sorbic acid Nutrition 0.000 claims description 8
- 239000004334 sorbic acid Substances 0.000 claims description 8
- 229940075582 sorbic acid Drugs 0.000 claims description 8
- 229940031439 squalene Drugs 0.000 claims description 8
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 8
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 8
- 239000004519 grease Substances 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 28
- 230000003266 anti-allergic effect Effects 0.000 abstract description 14
- 230000014759 maintenance of location Effects 0.000 abstract description 6
- 208000028990 Skin injury Diseases 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 45
- 210000003491 skin Anatomy 0.000 description 45
- 239000000047 product Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 18
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 15
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 15
- 229960002216 methylparaben Drugs 0.000 description 15
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 230000037307 sensitive skin Effects 0.000 description 9
- 230000008439 repair process Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002085 irritant Substances 0.000 description 5
- 231100000021 irritant Toxicity 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical group OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000003777 Interleukin-1 beta Human genes 0.000 description 2
- 108090000193 Interleukin-1 beta Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 102100029880 Glycodelin Human genes 0.000 description 1
- 101000585553 Homo sapiens Glycodelin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000004047 hyperresponsiveness Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a cosmetic composition comprising: glycerin, sodium hyaluronate, allantoin, dipotassium glycyrrhizinate, trehalose, bisabolol, panthenol, arginine and disodium ethylenediaminetetraacetate. The cosmetic composition disclosed by the invention is anti-allergic, better in repairing effect, better in moisture retention, milder, capable of relieving the skin sensitivity problem, and also has the effect of repairing skin injury and a better skin repairing effect.
Description
Technical Field
The invention relates to the field of cosmetics, and particularly relates to a cosmetic composition and application thereof.
Background
Modern people have fast pace of life, poor sleep, lack of skin care, increasingly serious environmental pollution, ultraviolet rays, radioactive rays, computer electric appliance radiation, smoking and drinking, excessive exercise, stress, excessive intake of processed food and grease which are too much eaten, and the like, which cause a plurality of skin problems.
The skin is an important component for maintaining the life and health of human body, is the first barrier of the body, is directly contacted with the outside, and is easily damaged by the influence of environmental factors. In recent years, people in a highly sensitive skin state have increased year by year due to air pollution, abuse of various industrial additives, change of life habits of people and the like, and skin allergy phenomena such as redness, swelling, heat, pain, itching, desquamation and the like are frequently generated and become a great factor influencing the appearance and health of people.
Sensitive skin is a high-response state of skin under physiological or pathological conditions, mainly occurs on the face, and is clinically characterized in that when the skin is stimulated by physical, chemical, mental and other factors, the skin is easy to have subjective symptoms such as burning, stabbing pain, pruritus, tightness and the like, and is accompanied or not accompanied by objective signs such as erythema, scale, telangiectasia and the like, and the sensitive skin cannot tolerate common cosmetics.
Sensitive skin is classified into primary and secondary, the former is caused by hereditary, age, spirit and other factors, and the latter is secondary to abused cosmetics, external irritant drugs, improper cosmetic treatment, certain skin diseases and the like. Sensitive skin is mainly associated with impaired skin barrier and abnormal nerve function, which can lead to the phenomena of damaged skin structure, dryness, tightness, redness, etc. Due to the characteristics of barrier function damage or nerve function abnormality of sensitive skin, the sensitive skin is more difficult to resist the invasion of external irritants and allergens compared with normal skin, a series of irritation or skin inflammatory reactions caused by allergy are easy to occur, and then the barrier structure and nerve endings of the skin are further damaged, so that the vicious circle is caused.
Sensitive skin is not actually a disease, it refers to a state of physiological hyperresponsiveness of the skin to environmental or internal factors (Italy). This condition can occur when exposed to cosmetics, soaps, sunscreen products, detergents, and can exacerbate common skin discomfort symptoms in dry and cold environments. Most of the existing anti-allergy products are added with some irritant raw materials, the components are complex, and the skin tolerance is weakened due to some anaphylactic reaction caused by the inadaptability of the skin. Meanwhile, most anti-allergy products neglect the reconstruction capability of the skin self-repair system, and increase the dosage of the reagent can increase the skin pressure, so that the skin is more sensitive.
Patent CN102988199A discloses a skin-tendering and anti-allergy essence, which is prepared from 1, 3-dihydroxybutane, propylene glycol, sodium pyrrolidone carboxylate, dimethyl glycyrrhizinate, algal polysaccharides, water-soluble vitamin E and other raw materials through the processes of heating, emulsifying, stirring, cooling and the like. Compared with the prior art, the patent has the following advantages: 1. the skin care effect is good: the facial skin of people can be tender; 2. and (3) antiallergic: the formulation contains dipotassium glycyrrhizinate and antiallergic agent, so that the composition can be used by people with sensitive skin; 3. simple production process and low cost. However, the components of the patent are complex, and the small molecular emulsifier such as sodium hydroxide solution which is possibly permeated into the horny layer can cause excessive skin irritation, and the banana is adopted to increase the irritation.
Therefore, in the cosmetic field, there is a strong demand for cosmetic compositions that are more resistant to allergy, better in the repair effect, better in the moisturizing type, and milder.
Disclosure of Invention
In view of the above, the invention aims to provide a cosmetic composition which is anti-allergic, better in repairing effect, better in moisturizing type and milder, can relieve the skin sensitivity problem, has the effect of repairing skin injury, and has a better skin repairing effect.
Therefore, the invention provides the following technical scheme.
In a first aspect, the present invention provides a cosmetic composition, wherein the composition comprises: glycerin, sodium hyaluronate, allantoin, dipotassium glycyrrhizinate, trehalose, bisabolol, panthenol, arginine and disodium ethylenediaminetetraacetate.
In a preferred embodiment, the composition further comprises: polyhydric alcohol, grease, macromolecular emulsifier, thickener and preservative.
In a preferred embodiment, the composition may further comprise water.
In a more preferred embodiment of the present invention,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
The preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a preferred embodiment, wherein, in parts by weight, the composition comprises:
2-4 parts glycerol, for example, the parts by weight of glycerol may be 2, 2.2, 2.5, 2.7, 3, 3.2, 3.5 or 4;
0.1 to 0.5 parts sodium hyaluronate, for example, the parts by weight of sodium hyaluronate may be 0.1, 0.2, 0.3, 0.4 or 0.5;
0.01-0.2 parts allantoin, for example the weight parts of allantoin may be 0.01, 0.03, 0.05, 0.07, 0.09, 0.1, 0.15 or 0.2;
0.2-0.5 parts of dipotassium glycyrrhizinate, for example, the weight parts of dipotassium glycyrrhizinate can be 0.2, 0.25, 0.3, 0.35, 0.4, 0.45 or 0.5;
0.2-2 parts trehalose, for example, the trehalose may be in a weight part of 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2;
0.1-1 parts of bisabolol, for example, the parts by weight of the bisabolol may be 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1;
0.5 to 3 parts by weight of panthenol, which may be, for example, 0.5, 0.7, 1, 1.5, 1.7, 2, 2.5, 2.7 or 3;
0.1-0.7 parts arginine, e.g., the parts by weight of arginine may be 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, or 0.7;
and 0.01 to 0.1 parts of disodium ethylenediaminetetraacetate, which may be, for example, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, or 0.1 parts by weight.
In a preferred embodiment, wherein, according to parts by weight, the composition further comprises:
1-4 parts polyol, for example, the parts by weight of the polyol can be 1, 1.5, 2, 2.5, 3, 3.5, or 4;
0.2 to 1.2 parts of an oil, for example, the parts by weight of the oil may be 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1 or 1.2;
0.2 to 1 part of macromolecular emulsifier, for example, the parts by weight of macromolecular emulsifier may be 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1;
0.1 to 0.6 parts of thickener, for example, the parts by weight of the thickener may be 0.1, 0.2, 0.3, 0.4, 0.5 or 0.6;
and 0.3 to 0.7 parts preservative, for example, the preservative may be present in an amount of 0.3, 0.4, 0.5, 0.6 or 0.7 parts by weight.
In a more preferred embodiment of the present invention,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a second aspect, the present invention provides a cosmetic composition, wherein, in parts by weight:
The composition comprises: 2-4 parts of glycerol, 1-4 parts of polyalcohol, 0.1-0.5 part of sodium hyaluronate, 0.2-1.2 parts of grease, 0.2-1 part of macromolecular emulsifier, 0.01-0.2 part of allantoin, 0.2-0.5 part of dipotassium glycyrrhizinate, 0.2-2 parts of trehalose, 0.1-1 part of bisabolol, 0.5-3 parts of panthenol, 0.1-0.6 part of thickener, 0.1-0.7 part of arginine, 0.3-0.7 part of preservative and 0.01-0.1 part of disodium ethylenediamine tetraacetate.
In a preferred embodiment of the present invention,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
The preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a third aspect, the present invention provides a cosmetic composition, wherein, in parts by weight:
the composition comprises: 3 parts of glycerol, 2 parts of polyhydric alcohol, 0.3 part of sodium hyaluronate, 1 part of grease, 0.5 part of macromolecular emulsifier, 0.1 part of allantoin, 0.3 part of dipotassium glycyrrhizinate, 1.5 parts of trehalose, 0.5 part of bisabolol, 2.5 parts of panthenol, 0.5 part of thickener, 0.2 part of arginine, 0.6 part of preservative and 0.03 part of disodium ethylenediamine tetraacetate.
In a preferred embodiment of the present invention,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
The thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a fourth aspect, the present invention provides a method for preparing a cosmetic composition, the method comprising the steps of:
the method comprises the following steps: mixing polyalcohol, glycerol, sodium hyaluronate, trehalose, thickener and macromolecular emulsifier, heating to 75-85 deg.C, stirring to dissolve;
step two: dissolving oil and fat, bisabolol and dipotassium glycyrrhizinate in the material obtained in the first step, mixing and heating to 75-85 ℃, and stirring to dissolve;
step three: mixing the materials obtained in step two in a container, adding arginine to adjust pH when the temperature is reduced to 40-50 ℃, adding allantoin, panthenol, antiseptic and disodium ethylene diamine tetraacetate, and stirring uniformly.
In a preferred embodiment, the cosmetic composition is the cosmetic composition described in the present specification.
In a preferred embodiment of the present invention,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
In a fifth aspect, a cosmetic product is provided, the cosmetic product comprising the cosmetic composition of the present invention.
In a sixth aspect, a pharmaceutical composition is provided comprising a safe and effective amount of a cosmetic composition according to the present invention.
In addition, the invention also provides the application of the cosmetic composition in preparing cosmetic products.
And the use of the cosmetic composition of the present invention in the preparation of a pharmaceutical composition is provided.
In the present invention, polyols are a class of water-soluble substances that can moisturize the skin or reduce the transdermal water loss from the skin.
In the present invention, the oil component can form a hydrophobic film on the skin surface, which imparts softness, smoothness, gloss and elasticity to the skin, while preventing the invasion of external harmful substances and protecting against the erosion from natural factors; inhibiting skin dryness and water evaporation from the skin surface in cold; the massage cream has the function of lubricating and reducing friction when massaging skin.
The emulsifier can improve the surface tension between various constituent phases in the emulsion, so that a uniform and stable dispersion system or an emulsion substance is formed; emulsifiers are surface-active substances which have both hydrophilic and lipophilic groups in the molecule and which accumulate at the oil/water interface and reduce the interfacial tension and the energy required to form an emulsion, thereby increasing the energy of the emulsion. In the invention, the used macromolecular emulsifier can not permeate below the stratum corneum of the skin and can not cause irritation to the skin; while the general emulsifier may penetrate into the dermis layer, causing excessive irritation to the skin.
In the present invention, the thickener has an important influence on the appearance and shape of the product. The thickener enables the system to achieve the thickening purpose through a rod-shaped micelle formed by the thickener and a surfactant, a three-dimensional hydration network structure formed by the action of the thickener and water, a self macromolecular long-chain structure and the like.
In the present invention, a preservative means a substance added to an agent composition for skin care for the purpose of inhibiting the growth and proliferation of microorganisms in the agent composition for skin care, to prolong the shelf life of the agent composition for skin care.
In the present invention, the cosmetic product may include, as desired, a container, instructions for use, use aids, and/or other structures and/or agents necessary for performing the performance test; adjuvants used in the cosmetic products of the present invention include, but are not limited to, oils, emulsifiers, moisturizers, thickeners, skin conditioners, and/or preservatives; other structures required for performing performance tests in the cosmetic products of the present invention include, but are not limited to, structures for sampling, structures for performing control, and/or structures for observing the course or result of the assay; the other agents required for performing performance tests in the skin care products of the present invention include, but are not limited to, culture media, detergents, developers, and/or terminators.
In the present invention, the pharmaceutical composition comprises the cosmetic composition of the present invention and a pharmaceutically acceptable excipient.
In the present invention, a safe and effective amount refers to an amount of a compound or composition sufficient to significantly induce a positive benefit, preferably a positive skin tissue appearance or feel benefit, including the benefits disclosed herein, either individually or in combination, but low enough to avoid serious side effects, i.e., to provide a reasonable benefit to risk ratio, within the scope of sound judgment of the skilled artisan.
Compared with the prior art, the invention has the beneficial effects that:
the sodium hyaluronate used in the cosmetic composition disclosed by the invention is used as a natural macromolecular humectant, has very strong water retention capacity, and can keep skin moist, smooth, fine, tender and elastic within a certain time; the used oil can strengthen the oil barrier, supplement skin lipid and repair keratinocytes; the used macromolecular emulsifier can not permeate below the stratum corneum of the skin, so that a stimulus is avoided; the allantoin used can promote tissue growth and cell metabolism, soften stratum corneum protein, accelerate wound healing and increase skin brightness; the dipotassium glycyrrhizinate used can reduce the expression of proinflammatory hormones TNF-alpha, IL-6, IL-1 beta and IL-8; the trehalose used as a natural saccharide has good affinity with membrane protein, can increase the hydration function of cells, has good moisture retention, can form a layer of special protective film on the cell surface under a dry condition, can bind water molecules under the hydration function, and can also play a role in replacing water in the cells when water is lost, thereby protecting skin cells from being damaged; the used bisabolol can reduce the expression of proinflammatory hormones TNF-alpha, IL-6, IL-1 alpha, IL-1 beta and PEG 2; the used panthenol can stimulate the growth of epithelial cells, promote wound healing and has an anti-inflammatory effect; the used arginine has high safety, has skin moisturizing effect, and can be used for wound healing.
By screening the types of the components in the cosmetic composition and adjusting the content of the components in the cosmetic composition, the cosmetic composition has better anti-allergy and repairing effects, better moisturizing type and milder property.
Detailed Description
The present invention will be described in detail below with reference to specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly apparent therefrom. It will be understood by those skilled in the art that these specific embodiments and examples are for the purpose of illustrating the invention and are not to be construed as limiting the invention.
Example 1
The present example provides a cosmetic composition, comprising, in parts by weight:
2 parts of glycerol, 1 part of propylene glycol, 0.1 part of sodium hyaluronate, 0.2 part of squalane, 0.2 part of cetearyl glucoside, 0.01 part of allantoin, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of trehalose, 0.1 part of bisabolol, 0.5 part of panthenol, 0.1 part of xanthan gum, 0.1 part of arginine, 0.3 part of methylparaben, 0.01 part of disodium edetate and a proper amount of water.
The cosmetic composition of this example was prepared by a process comprising:
the method comprises the following steps: mixing 1 part of propylene glycol, 2 parts of glycerol, 0.1 part of sodium hyaluronate, 0.2 part of trehalose, 0.1 part of xanthan gum, 0.2 part of cetearyl glucoside and a proper amount of water, heating to 80 ℃, and stirring to dissolve the mixture;
Step two: dissolving 0.2 part of squalane, 0.1 part of bisabolol and 0.2 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.1 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.01 part of allantoin, 0.5 part of panthenol, 0.3 part of methylparaben and 0.01 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Example 2
The present example provides a cosmetic composition, wherein the composition comprises, in parts by weight:
4 parts of glycerol, 4 parts of propylene glycol, 0.5 part of sodium hyaluronate, 1.2 parts of squalane, 1 part of cetearyl glucoside, 0.2 part of allantoin, 0.5 part of dipotassium glycyrrhizinate, 2 parts of trehalose, 1 part of bisabolol, 3 parts of panthenol, 0.6 part of xanthan gum, 0.7 part of arginine, 0.7 part of methylparaben, 0.1 part of disodium edetate and a proper amount of water.
The cosmetic composition of this example was prepared by a process comprising:
the method comprises the following steps: mixing 4 parts of propylene glycol, 4 parts of glycerol, 0.5 part of sodium hyaluronate, 2 parts of trehalose, 0.6 part of xanthan gum, 1 part of cetearyl glucoside and a proper amount of water, heating to 80 ℃, and stirring to dissolve;
Step two: dissolving 1.2 parts of squalane, 1 part of bisabolol and 0.5 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.7 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.2 part of allantoin, 3 parts of panthenol, 0.7 part of methylparaben and 0.1 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Example 3
The present example provides a cosmetic composition, comprising, in parts by weight:
3 parts of glycerol, 2 parts of propylene glycol, 0.3 part of sodium hyaluronate, 1 part of squalane, 0.5 part of cetearyl glucoside, 0.1 part of allantoin, 0.3 part of dipotassium glycyrrhizinate, 1.5 parts of trehalose, 0.5 part of bisabolol, 2.5 parts of panthenol, 0.5 part of xanthan gum, 0.2 part of arginine, 0.6 part of methylparaben, 0.03 part of disodium edetate and a proper amount of water.
The cosmetic composition of this example was prepared by a process comprising:
the method comprises the following steps: mixing 2 parts of propylene glycol, 3 parts of glycerol, 0.3 part of sodium hyaluronate, 1.5 parts of trehalose, 0.5 part of xanthan gum, 0.5 part of cetearyl glucoside and a proper amount of water, heating to 80 ℃, and stirring to dissolve;
Step two: dissolving 1 part of squalane, 0.5 part of bisabolol and 0.3 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.2 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.1 part of allantoin, 2.5 parts of panthenol, 0.6 part of methylparaben and 0.03 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Example 4
The present embodiment provides a cosmetic product, comprising, in parts by weight:
2 parts of glycerol, 1 part of propylene glycol, 0.1 part of sodium hyaluronate, 0.2 part of squalane, 0.2 part of cetearyl glucoside, 0.01 part of allantoin, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of trehalose, 0.1 part of bisabolol, 0.5 part of panthenol, 0.1 part of xanthan gum, 0.1 part of arginine, 0.3 part of methylparaben, 0.01 part of disodium edetate and a proper amount of water.
The cosmetic product of this example was prepared by a method comprising:
the method comprises the following steps: mixing 1 part of propylene glycol, 2 parts of glycerol, 0.1 part of sodium hyaluronate, 0.2 part of trehalose, 0.1 part of xanthan gum, 0.2 part of cetearyl glucoside and a proper amount of water, heating to 80 ℃, and stirring to dissolve;
Step two: dissolving 0.2 part of squalane, 0.1 part of bisabolol and 0.2 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.1 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.01 part of allantoin, 0.5 part of panthenol, 0.3 part of methylparaben and 0.01 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Example 5
The present embodiment provides a cosmetic product, wherein the cosmetic product comprises, in parts by weight:
4 parts of glycerol, 4 parts of propylene glycol, 0.5 part of sodium hyaluronate, 1.2 parts of squalane, 1 part of cetearyl glucoside, 0.2 part of allantoin, 0.5 part of dipotassium glycyrrhizinate, 2 parts of trehalose, 1 part of bisabolol, 3 parts of panthenol, 0.6 part of xanthan gum, 0.7 part of arginine, 0.7 part of methylparaben, 0.1 part of disodium edetate and a proper amount of water.
The cosmetic product of this example was prepared by a method comprising:
the method comprises the following steps: mixing 4 parts of propylene glycol, 4 parts of glycerol, 0.5 part of sodium hyaluronate, 2 parts of trehalose, 0.6 part of xanthan gum and 1 part of cetearyl glucoside with a proper amount of water, heating to 80 ℃, and stirring to dissolve;
Step two: dissolving 1.2 parts of squalane, 1 part of bisabolol and 0.5 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.7 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.2 part of allantoin, 3 parts of panthenol, 0.7 part of methylparaben and 0.1 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Example 6
The present embodiment provides a cosmetic product, comprising, in parts by weight:
3 parts of glycerol, 2 parts of propylene glycol, 0.3 part of sodium hyaluronate, 1 part of squalane, 0.5 part of cetearyl glucoside, 0.1 part of allantoin, 0.3 part of dipotassium glycyrrhizinate, 1.5 parts of trehalose, 0.5 part of bisabolol, 2.5 parts of panthenol, 0.5 part of xanthan gum, 0.2 part of arginine, 0.6 part of methylparaben, 0.03 part of disodium edetate and a proper amount of water.
The cosmetic product of this example was prepared by a method comprising:
the method comprises the following steps: mixing 2 parts of propylene glycol, 3 parts of glycerol, 0.3 part of sodium hyaluronate, 1.5 parts of trehalose, 0.5 part of xanthan gum, 0.5 part of cetearyl glucoside and a proper amount of water, heating to 80 ℃, and stirring to dissolve;
Step two: dissolving 1 part of squalane, 0.5 part of bisabolol and 0.3 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.2 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.1 part of allantoin, 2.5 parts of panthenol, 0.6 part of methylparaben and 0.03 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Comparative example 1
In order to further illustrate the beneficial effects of the invention, the skin-tendering and anti-allergy essence is provided, and the essence is prepared by adopting the method in patent CN 102988199A.
Comparative example 2
To further illustrate the beneficial effects of the present invention, comparative example 2 is provided, which comparative example 2 differs from example 3 in that: cetearyl glucoside of the present invention was replaced with PEG-9 dimethiconoethyl dimethicone.
Comparative example 2 provides a cosmetic composition prepared by a method comprising:
the method comprises the following steps: mixing 2 parts of propylene glycol, 3 parts of glycerol, 0.3 part of sodium hyaluronate, 1.5 parts of trehalose, 0.5 part of xanthan gum, 0.5 part of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane and a proper amount of water, heating to 80 ℃, and stirring to dissolve the materials;
Step two: dissolving 1 part of squalane, 0.5 part of bisabolol and 0.3 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
step three: and (3) mixing the materials obtained in the step two in a container, adding 0.2 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.1 part of allantoin, 2.5 parts of panthenol, 0.6 part of methylparaben and 0.03 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Comparative example 3
To further illustrate the beneficial effects of the present invention, comparative example 3 is provided, which is different from example 6 in that: cetearyl glucoside of the present invention was replaced with PEG-9 dimethiconoethyl dimethicone.
Comparative example 3 provides a cosmetic product prepared by a method comprising:
the method comprises the following steps: mixing 2 parts of propylene glycol, 3 parts of glycerol, 0.3 part of sodium hyaluronate, 1.5 parts of trehalose, 0.5 part of xanthan gum, 0.5 part of PEG-9 polydimethylsiloxyethyl polydimethylsiloxane and a proper amount of water, heating to 80 ℃, and stirring to dissolve the materials;
step two: dissolving 1 part of squalane, 0.5 part of bisabolol and 0.3 part of dipotassium glycyrrhizinate in the material obtained in the step one, mixing and heating to 80 ℃, and stirring to dissolve;
Step three: and (3) mixing the materials obtained in the step two in a container, adding 0.2 part of arginine to adjust the pH when the temperature is reduced to 45 ℃, adding 0.1 part of allantoin, 2.5 parts of panthenol, 0.6 part of methylparaben and 0.03 part of disodium ethylene diamine tetraacetate, and uniformly stirring.
Experiment 1: effect verification
And (3) testing a sample: the present specification shows the samples prepared in examples 1 to 6 and comparative examples 1 to 3.
The experimental method comprises the following steps: 90 facial allergy-prone volunteers were selected, with an age distribution of 15-40 years, and randomized into A, B, C, D, E, F, G, H, I nine groups of 10 people each. Wherein,
group a applied the cosmetic composition prepared by the above example 1 of the present invention,
group B applied the cosmetic composition prepared by the above example 2 of the present invention,
group C the cosmetic composition prepared by the above example 3 of the present invention was applied,
group D applied the cosmetic product prepared by the above-mentioned example 4 of the present invention,
group E applied the cosmetic product prepared by the above example 5 of the present invention,
group F applied the cosmetic product prepared by the above-described example 6 of the present invention,
group G applied the essence prepared in comparative example 1,
group H applied the cosmetic composition prepared in comparative example 2,
group I application of the cosmetic product prepared in comparative example 3,
The preparation is administered once a day, and 10 days later. The evaluation score was 10 points, and the test evaluation results are shown in table 1 below.
TABLE 1
Evaluation item | Anti-allergic effect | Repairing effects | Mildness property | Moisture retention |
Example 1 | 8.4 | 8.5 | 8.2 | 8.2 |
Example 2 | 8.6 | 8.2 | 8.3 | 8.6 |
Example 3 | 9.6 | 9.4 | 9.7 | 9.5 |
Example 4 | 8.7 | 8.3 | 8.2 | 8.6 |
Example 5 | 8.1 | 8.6 | 8.9 | 8.3 |
Example 6 | 9.2 | 9.5 | 9.3 | 9.7 |
Comparative example 1 | 5.8 | 6.2 | 5.9 | 6.1 |
Comparative example 2 | 5.6 | 5.5 | 5.6 | 5.8 |
Comparative example 3 | 5.6 | 5.7 | 5.7 | 5.1 |
Likewise, to further illustrate the beneficial effects of the present invention, the following comparative examples are provided:
comparative example 2.1 is provided, which is distinguished from example 3 by the following: the methylparaben of the present invention is replaced with salicylic acid.
The cosmetic composition prepared in conjunction with the preparation method of the present invention was tested according to the test method of experiment 1. The skin care results of the cosmetic composition prepared in comparative example 2.1 were observed. The results were similar to those in group H above.
From the above results, it can be seen that:
the cosmetic composition provided by the invention can achieve good anti-allergy effect and repair effect, has better moisture retention and milder property, has no irritation to skin, and has the effect of more than 8 minutes. By screening the types of the components in the cosmetic composition or adjusting the weight parts of the components in the cosmetic composition, the anti-allergy effect and the repair effect are remarkable, the moisturizing effect is mild, the skin is not irritated, the result is more than 9 minutes, and the cosmetic composition has the effects of relieving the skin allergy problem, repairing skin injury, having a good skin repair effect and being mild and non-irritant. The cosmetic composition has certain moisture retention, but has obviously poor anti-allergy effect, and the facial sensitivity of the volunteers is not improved basically.
Similarly, the cosmetic product provided by the invention can achieve good anti-allergy effect and repair effect, has better moisture retention and milder property, has no irritation to skin, and has the effect of more than 8 minutes. By screening the types of the components in the cosmetic composition or adjusting the weight parts of the components in the cosmetic composition, the anti-allergy effect and the repair effect are remarkable, the moisturizing effect is mild, the skin is not irritated, the result is more than 9 minutes, and the cosmetic composition has the effects of relieving the skin allergy problem, repairing skin injury, having a good skin repair effect and being mild and non-irritant.
Moreover, the cosmetic composition and the cosmetic product have fewer components, simpler production operation and lower production cost.
It is to be understood that the invention disclosed is not limited to the particular methodology, protocols, and materials described, as these may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention which will be limited only by the appended claims.
Those skilled in the art will also recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
Claims (10)
1. A cosmetic composition, wherein the composition comprises: glycerin, sodium hyaluronate, allantoin, dipotassium glycyrrhizinate, trehalose, bisabolol, panthenol, arginine and disodium ethylenediaminetetraacetate.
2. The composition of claim 1, further comprising: polyhydric alcohol, grease, macromolecular emulsifier, thickener and preservative; wherein,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
The thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
3. The composition of claim 1, wherein the weight parts of:
the composition comprises: 2-4 parts of glycerin, 0.1-0.5 part of sodium hyaluronate, 0.01-0.2 part of allantoin, 0.2-0.5 part of dipotassium glycyrrhizinate, 0.2-2 parts of trehalose, 0.1-1 part of bisabolol, 0.5-3 parts of panthenol, 0.1-0.7 part of arginine and 0.01-0.1 part of disodium ethylenediamine tetraacetate.
4. The composition according to claim 2, wherein the weight parts of the composition are as follows:
the composition further comprises: 1-4 parts of polyhydric alcohol, 0.2-1.2 parts of grease, 0.2-1 part of macromolecular emulsifier, 0.1-0.6 part of thickening agent and 0.3-0.7 part of preservative.
5. A cosmetic composition comprises the following components in parts by weight:
the composition comprises: 2-4 parts of glycerol, 1-4 parts of polyhydric alcohol, 0.1-0.5 part of sodium hyaluronate, 0.2-1.2 parts of grease, 0.2-1 part of macromolecular emulsifier, 0.01-0.2 part of allantoin, 0.2-0.5 part of dipotassium glycyrrhizinate, 0.2-2 parts of trehalose, 0.1-1 part of bisabolol, 0.5-3 parts of panthenol, 0.1-0.6 part of thickener, 0.1-0.7 part of arginine, 0.3-0.7 part of preservative and 0.01-0.1 part of disodium ethylenediamine tetraacetate; wherein,
The polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
the preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
6. A method of preparing a cosmetic composition, the method comprising the steps of:
the method comprises the following steps: mixing polyalcohol, glycerol, sodium hyaluronate, trehalose, thickener and macromolecular emulsifier, heating to 75-85 deg.C, stirring to dissolve;
Step two: dissolving oil and fat, bisabolol and dipotassium glycyrrhizinate in the material obtained in the first step, mixing and heating to 75-85 ℃, and stirring to dissolve;
step three: mixing the materials obtained in the step two in a container, adding arginine to adjust the pH when the temperature is reduced to 40-50 ℃, adding allantoin, panthenol, a preservative and disodium ethylene diamine tetraacetate, and uniformly stirring; wherein,
the polyalcohol is one or more selected from pentanediol, butanediol, propanediol and hexanediol;
the oil is selected from one or more of squalene, squalane, hydrogenated polydecene, hydrogenated polyisobutene and jojoba oil;
the macromolecular emulsifier is one or more selected from PEG-20 methyl glucose sesquistearate, PEG-150 distearate, PEG-100 distearate, PEG-40 hydrogenated castor oil, sorbitan olivate, cetearyl glucoside, PEG-11 methyl ether polydimethylsiloxane and PEG-20 sorbitan cocoate;
the thickening agent is one or more of carbomer, xanthan gum, sodium carrageenan, Arabic gum, polyethylene glycol-14M, polyethylene glycol-90M, succinoglycan, hydroxyethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose;
The preservative is selected from one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, glyceryl caprylate, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, caprylyl hydroximic acid and glyceryl caprylate.
7. The method of claim 6, wherein the cosmetic composition is the cosmetic composition of any one of claims 1-5.
8. A cosmetic product, wherein the cosmetic product comprises the cosmetic composition of any one of claims 1 to 5.
9. A pharmaceutical composition comprising a safe and effective amount of the cosmetic composition of any one of claims 1 to 5.
10. Use of a cosmetic composition according to any one of claims 1 to 5 for the preparation of a cosmetic or pharmaceutical product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910440904.9A CN111973471A (en) | 2019-05-24 | 2019-05-24 | Cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910440904.9A CN111973471A (en) | 2019-05-24 | 2019-05-24 | Cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111973471A true CN111973471A (en) | 2020-11-24 |
Family
ID=73436781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910440904.9A Withdrawn CN111973471A (en) | 2019-05-24 | 2019-05-24 | Cosmetic composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111973471A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972360A (en) * | 2021-03-03 | 2021-06-18 | 上海好肌茵生物科技有限公司 | Sensitive repairing composition and preparation method and application thereof |
CN115919706A (en) * | 2023-03-06 | 2023-04-07 | 天津郁美净集团有限公司 | Skin care product for improving skin irritation and tolerance and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048666A (en) * | 2010-11-26 | 2011-05-11 | 新时代健康产业(集团)有限公司 | Skin care composition with wrinkle removing and resisting function and preparation and preparation method thereof |
CN106265273A (en) * | 2016-08-30 | 2017-01-04 | 王乔 | A kind of whitening and skin-protecting emulsion containing jasmin quintessence oil |
CN106619329A (en) * | 2017-02-16 | 2017-05-10 | 广州市爱百伊生物技术有限公司 | Eye elastic essence milk and preparation method thereof |
CN107137243A (en) * | 2017-06-12 | 2017-09-08 | 南京凯创协同纳米技术有限公司 | Anti-acne facial treatment milk and preparation method thereof |
CN108670878A (en) * | 2018-08-01 | 2018-10-19 | 养生堂(安吉)化妆品有限公司 | The cosmetic composition of anti-skin allergy |
CN108938489A (en) * | 2018-08-21 | 2018-12-07 | 广东博然堂生物科技有限公司 | A kind of plant composition for skin care, frost and preparation method thereof of releiving |
-
2019
- 2019-05-24 CN CN201910440904.9A patent/CN111973471A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048666A (en) * | 2010-11-26 | 2011-05-11 | 新时代健康产业(集团)有限公司 | Skin care composition with wrinkle removing and resisting function and preparation and preparation method thereof |
CN106265273A (en) * | 2016-08-30 | 2017-01-04 | 王乔 | A kind of whitening and skin-protecting emulsion containing jasmin quintessence oil |
CN106619329A (en) * | 2017-02-16 | 2017-05-10 | 广州市爱百伊生物技术有限公司 | Eye elastic essence milk and preparation method thereof |
CN107137243A (en) * | 2017-06-12 | 2017-09-08 | 南京凯创协同纳米技术有限公司 | Anti-acne facial treatment milk and preparation method thereof |
CN108670878A (en) * | 2018-08-01 | 2018-10-19 | 养生堂(安吉)化妆品有限公司 | The cosmetic composition of anti-skin allergy |
CN108938489A (en) * | 2018-08-21 | 2018-12-07 | 广东博然堂生物科技有限公司 | A kind of plant composition for skin care, frost and preparation method thereof of releiving |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972360A (en) * | 2021-03-03 | 2021-06-18 | 上海好肌茵生物科技有限公司 | Sensitive repairing composition and preparation method and application thereof |
CN112972360B (en) * | 2021-03-03 | 2023-04-07 | 上海好肌茵生物科技有限公司 | Sensitive repairing composition and preparation method and application thereof |
CN115919706A (en) * | 2023-03-06 | 2023-04-07 | 天津郁美净集团有限公司 | Skin care product for improving skin irritation and tolerance and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111249209B (en) | Moisturizing repair cream and preparation method thereof | |
CN109157453B (en) | Skin-friendly sustained-release composition and cosmetic thereof | |
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
CN112263497A (en) | Skin care product composition with effects of relieving, repairing and resisting allergy | |
CN114177109B (en) | Composite ceramide nano composition and preparation method and application thereof | |
JP2001510487A (en) | Composition comprising a combination of free sphingoid base and ceramide and use thereof | |
CN111265468A (en) | Skin double-barrier repair composition and application thereof | |
KR102594286B1 (en) | Moisturizer | |
CN108969446A (en) | It is a kind of enhance skin barrier function infant prevent chapped skin care compositions and preparation method thereof | |
CN112137951A (en) | Silicone-oil-free transparent amino acid shampoo capable of strengthening hair and repairing scalp barrier and preparation method thereof | |
CN111067828A (en) | Cosmetic composition for anti-allergy repair | |
KR20210053638A (en) | cosmetic composition for improving skin condition and manufacturing method thereof | |
US20150118334A1 (en) | Topical compositions for the treatment of chronic inflammatory skin disease | |
CN113456568A (en) | Composition for soothing, repairing and moisturizing skin and preparation method and application thereof | |
CN111973471A (en) | Cosmetic composition | |
CN110101591B (en) | Long-acting moisturizing composition and preparation method and application thereof | |
CN108721154B (en) | Skin care product for skin moisturizing and barrier repair and preparation method thereof | |
CN111214418A (en) | Efficient barrier repair composition and application thereof | |
WO2013190542A2 (en) | Topical compositions for the treatment of chronic inflammatory skin disease | |
CN117815095A (en) | Composition with relieving and repairing effects and preparation method thereof | |
US20060275239A1 (en) | Depolymerized scleroglucan for regulating and improving the moisture content of the skin | |
CN112716849A (en) | Anti-chap skin cream containing camellia oleifera extract | |
CN115040438B (en) | Skin composition for promoting skin barrier repair function, preparation method and application thereof | |
CN110302136A (en) | Whitening and skin-protecting composition | |
WO2023104843A1 (en) | Topical preparation for enhancing skin condition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20201124 |
|
WW01 | Invention patent application withdrawn after publication |